Harbin Pharmaceutical Group Co Ltd (600664) — Financial Flexibility Index
Harbin Pharmaceutical Group Co Ltd (600664) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-159.00 Million (operating CF CN¥-192.19 Million minus capex CN¥33.19 Million) represents 0% of total liabilities (CN¥7.67 Billion). Check Harbin Pharmaceutical Group Co Ltd (600664) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Harbin Pharmaceutical Group Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see 600664 operating cash flow.
Annual Financial Flexibility Index for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Harbin Pharmaceutical Group Co Ltd. Explore cash flow to debt ratio of Harbin Pharmaceutical Group Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | CN¥893.31 Million | CN¥792.50 Million | CN¥8.53 Billion | ▼ -12.1% |
| 2023 | 0.12x | CN¥1.04 Billion | CN¥949.67 Million | CN¥8.69 Billion | ▲ +42.2% |
| 2022 | 0.08x | CN¥711.74 Million | CN¥622.09 Million | CN¥8.48 Billion | ▲ +923.9% |
| 2021 | -0.01x | CN¥-85.74 Million | CN¥-162.44 Million | CN¥8.42 Billion | ▲ +86.9% |
| 2020 | -0.08x | CN¥-609.94 Million | CN¥-728.15 Million | CN¥7.86 Billion | ▼ -107.0% |
| 2019 | -0.04x | CN¥-245.94 Million | CN¥-284.94 Million | CN¥6.56 Billion | ▼ -126.1% |
| 2018 | 0.14x | CN¥806.84 Million | CN¥692.72 Million | CN¥5.62 Billion | ▲ +255.3% |
| 2017 | 0.04x | CN¥251.23 Million | CN¥149.22 Million | CN¥6.22 Billion | ▼ -90.5% |
| 2016 | 0.43x | CN¥2.89 Billion | CN¥2.78 Billion | CN¥6.75 Billion | ▲ +37.6% |
| 2015 | 0.31x | CN¥1.95 Billion | CN¥1.66 Billion | CN¥6.28 Billion | ▲ +53.5% |
| 2014 | 0.20x | CN¥1.51 Billion | CN¥1.14 Billion | CN¥7.47 Billion | ▲ +203.7% |
| 2013 | 0.07x | CN¥511.54 Million | CN¥141.64 Million | CN¥7.68 Billion | ▼ -44.0% |
| 2012 | 0.12x | CN¥833.61 Million | CN¥557.83 Million | CN¥7.02 Billion | ▲ +208.5% |
| 2011 | 0.04x | CN¥202.06 Million | CN¥-31.56 Million | CN¥5.25 Billion | ▼ -86.2% |
| 2010 | 0.28x | CN¥1.45 Billion | CN¥1.15 Billion | CN¥5.22 Billion | ▼ -46.0% |
| 2009 | 0.52x | CN¥2.07 Billion | CN¥1.85 Billion | CN¥4.02 Billion | ▲ +178.3% |
| 2008 | 0.19x | CN¥721.67 Million | CN¥578.59 Million | CN¥3.89 Billion | ▼ -1.3% |
| 2007 | 0.19x | CN¥825.16 Million | CN¥650.16 Million | CN¥4.40 Billion | ▼ -21.8% |
| 2006 | 0.24x | CN¥1.06 Billion | CN¥738.08 Million | CN¥4.43 Billion | ▼ -15.3% |
| 2005 | 0.28x | CN¥1.20 Billion | CN¥757.76 Million | CN¥4.24 Billion | ▲ +76.0% |
| 2004 | 0.16x | CN¥577.60 Million | CN¥149.01 Million | CN¥3.59 Billion | ▼ -28.5% |
| 2003 | 0.23x | CN¥776.56 Million | CN¥302.83 Million | CN¥3.45 Billion | ▼ -10.6% |
| 2002 | 0.25x | CN¥774.47 Million | CN¥383.44 Million | CN¥3.08 Billion | ▼ -37.2% |
| 2001 | 0.40x | CN¥1.24 Billion | CN¥604.13 Million | CN¥3.09 Billion | ▲ +0.8% |
| 2000 | 0.40x | CN¥1.12 Billion | CN¥541.70 Million | CN¥2.82 Billion | ▲ +90.0% |
| 1999 | 0.21x | CN¥615.64 Million | CN¥431.22 Million | CN¥2.94 Billion | ▲ +52.4% |
| 1998 | 0.14x | CN¥322.14 Million | CN¥221.41 Million | CN¥2.34 Billion | — |